Suchergebnisse - "Ritonavir"

PubPharm (2.150)

41

Evaluation of apigenin-based biflavonoid derivatives as potential therapeutic agents against viral protease (3CLpro) of SARS-CoV-2 via molecular docking, molecular dynamics and quantum mechanics studies

enthalten in: Journal of biomolecular structure & dynamics | 2023

von Abdizadeh, R. | Hadizadeh, F. | Abdizadeh, T.

42

Ritonavir Revisited : Melt Crystallization Can Easily Find the Late-Appearing Polymorph II and Unexpectedly Discover a New Polymorph III

enthalten in: Molecular pharmaceutics | 2023

von Li, S. | Liu, B. | Chen, Z. | +3

43

Platform adaptive trial of novel antivirals for early treatment of COVID-19 In the community (PANORAMIC) : protocol for a randomised, controlled, open-label, adaptive platform trial of community novel antiviral treatment of COVID-19 in people at increased risk of more severe disease

enthalten in: BMJ open | 2023

von Gbinigie, O. | Ogburn, E. | Allen, J. | +45

44

Facilitating the drug repurposing with iC/E strategy : A practice on novel nNOS inhibitor discovery

enthalten in: Journal of bioinformatics and computational biology | 2023

von Hu, Z. | Liu, Q. | Ni, Z.

45

Pneumonia in newly diagnosed patients infected with the Omicron variant : a population-based study of Chinese patients in Chongqing

enthalten in: BMJ open respiratory research | 2023

von Wang, H. | Chen, R. | Guo, J. | +3

46

A yeast-based system to study SARS-CoV-2 Mpro structure and to identify nirmatrelvir resistant mutations

enthalten in: PLoS pathogens | 2023

von Ou, J. | Lewandowski, E. | Hu, Y. | +12

UpdateOf: bioRxiv. 2022 Aug 08;:. - PMID 35982672

47

Azvudine versus Paxlovid for oral treatment of COVID-19 in Chinese patients with pre-existing comorbidities

enthalten in: The Journal of infection | 2023

von Dian, Y. | Meng, Y. | Sun, Y. | +2

48

Paxlovid for hospitalized COVID-19 patients with chronic kidney disease

enthalten in: Antiviral research | 2023

von Cai, H. | Yan, J. | Liu, S. | +14

49

Triple Combination Therapy With 2 Antivirals and Monoclonal Antibodies for Persistent or Relapsed Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Immunocompromised Patients

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Mikulska, M. | Sepulcri, C. | Dentone, C. | +17

50

Real-World Evidence of the Top 100 Prescribed Drugs in the USA and Their Potential for Drug Interactions with Nirmatrelvir; Ritonavir

enthalten in: The AAPS journal | 2023

von Gerhart, J. | Draica, F. | Benigno, M. | +6